SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway
Background: Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent malignancies in the world, and tumor metastasis is still the main reason for disease progression. Accumulating evidence shows that SH3BGRL2 may play a key role in tumor progression and metastasis. However, the role of S...
Main Authors: | Lei Yin, Wenjia Li, Aiming Xu, Heng Shi, Keyi Wang, Huan Yang, Ronghao Wang, Bo Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396419308114 |
Similar Items
-
SH3BGRL2, a new downregulated tumor suppressor in clear cell renal cell carcinomas
by: Maeva Dufies
Published: (2020-02-01) -
The Role of SH3BGRL3 in Urothelial Carcinoma Progression
by: Cheng-YaoChiang, et al.
Published: (2015) -
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
by: Stern, Patrick, et al.
Published: (2013) -
SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane
by: Hui Li, et al.
Published: (2020-05-01) -
SH3BGRL3 binds to myosin 1c in a calcium dependent manner and modulates migration in the MDA-MB-231 cell line
by: Filippo Di Pisa, et al.
Published: (2021-08-01)